Ethnic differences in hepatic steatosis: An insulin resistance paradox?

Nonalcoholic fatty liver disease is a burgeoning problem. We have previously shown that Hispanics were at greater risk for nonalcoholic fatty liver disease than were African‐Americans despite a similar prevalence of risk factors between these groups. We have performed the largest, population‐based study to date (n = 2170) utilizing proton magnetic resonance (MR) spectroscopy, dual‐energy x‐ray absorptiometry, and multislice abdominal MR imaging to determine the contribution of body fat distribution to the differing prevalence of hepatic steatosis in the three major U.S. ethnic groups (African‐American, Hispanic, Caucasian). Despite controlling for age and total adiposity, African‐Americans had less intraperitoneal (IP) fat and more lower extremity fat than their Hispanic and Caucasian counterparts. The differences in hepatic triglyceride content (HTGC) between these groups remained after controlling for total, abdominal subcutaneous, and lower extremity adiposity; however, controlling for IP fat nearly abolished the differences in HTGC, indicating a close association between IP and liver fat regardless of ethnicity. Despite the lower levels of IP and liver fat in African‐Americans, their prevalence of insulin resistance was similar to Hispanics, who had the highest levels of IP and liver fat. Furthermore, insulin levels and homeostasis model assessment values were highest and serum triglyceride levels were lowest among African‐Americans after controlling for IP fat. Conclusion: IP fat is linked to HTGC, irrespective of ethnicity. The differing prevalence of hepatic steatosis between these groups was associated with similar differences in visceral adiposity. The metabolic response to obesity and insulin resistance differs in African‐Americans when compared to either Hispanics or Caucasians: African‐Americans appear to be more resistant to both the accretion of triglyceride in the abdominal visceral compartment (adipose tissue and liver) and hypertriglyceridemia associated with insulin resistance. (HEPATOLOGY 2009.)

[1]  Ja-june Jang,et al.  Visceral adipose tissue area is an independent risk factor for hepatic steatosis , 2008, Journal of gastroenterology and hepatology.

[2]  G. Stephanopoulos,et al.  Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. , 2008, Cell metabolism.

[3]  Y. Murawaki,et al.  The impact of visceral fat in nonalcoholic fatty liver disease: cross-sectional and longitudinal studies , 2007, Journal of Gastroenterology.

[4]  G. Shulman,et al.  Obesity-associated improvements in metabolic profile through expansion of adipose tissue. , 2007, The Journal of clinical investigation.

[5]  T. Pearson,et al.  Metabolic syndrome components in african-americans and European-american patients and its relation to coronary artery disease. , 2007, The American journal of cardiology.

[6]  S. Dufour,et al.  Interethnic Differences in Muscle, Liver and Abdominal Fat Partitioning in Obese Adolescents , 2007, PloS one.

[7]  S. Grundy,et al.  Influence of body fat content and distribution on variation in metabolic risk. , 2006, The Journal of clinical endocrinology and metabolism.

[8]  S. Giday,et al.  Frequency of nonalcoholic fatty liver disease and degree of hepatic steatosis in African-American patients. , 2006, Journal of the National Medical Association.

[9]  H. Conjeevaram,et al.  Metabolic Syndrome Is Associated with Greater Histologic Severity, Higher Carbohydrate, and Lower Fat Diet in Patients with NAFLD , 2006, The American Journal of Gastroenterology.

[10]  Yoichiro Kitajima,et al.  Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease , 2006, Journal of Gastroenterology.

[11]  Stanley Heshka,et al.  Independent association of insulin resistance with larger amounts of intermuscular adipose tissue and a greater acute insulin response to glucose in African American than in white nondiabetic women. , 2005, The American journal of clinical nutrition.

[12]  J. Jessurun,et al.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.

[13]  Tamara B Harris,et al.  Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue. , 2005, The American journal of clinical nutrition.

[14]  M. Manos,et al.  Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease , 2005, Hepatology.

[15]  S. Grundy,et al.  Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. , 2005, American journal of physiology. Endocrinology and metabolism.

[16]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[17]  M. Torbenson,et al.  Dietary Composition and Nonalcoholic Fatty Liver Disease , 2004, Digestive Diseases and Sciences.

[18]  D. Befroy,et al.  Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease* , 2004, Journal of Biological Chemistry.

[19]  Andrew R. Coggan,et al.  Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. , 2004, The New England journal of medicine.

[20]  Ronald M Peshock,et al.  The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. , 2004, The American journal of cardiology.

[21]  Donald D Hensrud,et al.  Splanchnic lipolysis in human obesity. , 2004, The Journal of clinical investigation.

[22]  J. Levy,et al.  Use and abuse of HOMA modeling. , 2004, Diabetes care.

[23]  M. Saboorian,et al.  Ethnic Differences in the Prevalence of Cryptogenic Cirrhosis , 2004, American Journal of Gastroenterology.

[24]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[25]  B. Gower,et al.  Using genetic admixture to explain racial differences in insulin-related phenotypes. , 2003, Diabetes.

[26]  Shankuan Zhu,et al.  The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. , 2003, Archives of internal medicine.

[27]  Xiao Man Yang,et al.  Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? , 2002, Diabetes.

[28]  J. Patrie,et al.  Is NASH underdiagnosed among African Americans? , 2002, American Journal of Gastroenterology.

[29]  G. Marchesini,et al.  Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. , 2001, Diabetes.

[30]  G. Marchesini,et al.  Association of nonalcoholic fatty liver disease with insulin resistance. , 1999, The American journal of medicine.

[31]  F. Schick,et al.  Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. , 1999, American journal of physiology. Endocrinology and metabolism.

[32]  N. Barzilai,et al.  Revisiting the role of fat mass in the life extension induced by caloric restriction. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.

[33]  C. Kahn,et al.  A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. , 1998, Molecular cell.

[34]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[35]  J. Lovejoy,et al.  Abdominal fat distribution and metabolic risk factors: effects of race. , 1996, Metabolism: clinical and experimental.

[36]  R. Bergman,et al.  Increased Insulin Resistance and Insulin Secretion in Nondiabetic African-Americans and Hispanics Compared With Non-Hispanic Whites: The Insulin Resistance Atherosclerosis Study , 1996, Diabetes.

[37]  S. Grundy,et al.  Relationships of generalized and regional adiposity to insulin sensitivity in men. , 1995, The Journal of clinical investigation.

[38]  C. Tiribelli,et al.  Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis , 1995, Journal of magnetic resonance imaging : JMRI.

[39]  D. Schuster,et al.  Ethnic Differences in Secretion, Sensitivity, and Hepatic Extraction of Insulin in Black and White Americans , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[40]  J. McGarry,et al.  What if Minkowski had been ageusic? An alternative angle on diabetes. , 1992, Science.

[41]  G. Reaven.  Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.

[42]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[43]  A. Tabesh,et al.  Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients. , 2005, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[44]  J. Ludwig,et al.  Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. , 1980, Mayo Clinic proceedings.

[45]  G. Shulman,et al.  On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance , 2022 .